EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Small Molecule SR8278 Inhibits Cell Proliferation Independent of the REV-ERB Nuclear Receptor Proteins in Human Keratinocytes

Ushaswini Atluri, William Cvammen iD, Michael G Kemp iD

Biomolecules · 2026

DOI: 10.3390/biom16030416 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, 2026. Verfasst von Ushaswini Atluri und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, Wright State University Boonshoft School of Medicine, Dayton, OH 45435, USA. Hauptthemen laut MEDLINE: Keratinocytes, Cell Proliferation, Thiophenes, Nuclear Receptor Subfamily 1, Group D, Member 1. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, National Institutes of Health, United States Department of Veterans Affairs.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The small molecule SR8278 was initially identified as an antagonist of the REV-ERB (reverse c-ERBAa) nuclear receptor proteins, which play important roles in metabolism and circadian rhythms. Though SR8278 has been shown to have beneficial physiological effects in a variety of different preclinical disease contexts, its impact on gene expression and cell proliferation in keratinocytes has not previously been examined. We therefore carried out an RNA-seq analysis and found that genes involved in the G1/S transition of the cell cycle were significantly impacted by SR8278 treatment, and these effects were confirmed at both the RNA and protein level by RT-qPCR and Western blotting, respectively. Cell proliferation assays showed that SR8278 slowed cell growth but did not induce genotoxic stress or apoptosis. Finally, the use of CRISPR/Cas9 genome editing and siRNA-mediated disruption of REV-ERB gene expression showed that the loss of the REV-ERB proteins did not impact the effect of SR8278 on gene expression and cell proliferation. We conclude that the anti-proliferative effects of SR8278 are not mediated by the REV-ERB proteins, and, thus, care should be taken when interpreting studies involving this compound unless complementary genetic approaches are also shown, particularly in studies involving cell proliferation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

KeratinocytesCell ProliferationThiophenesNuclear Receptor Subfamily 1, Group D, Member 1HumansGene Expression RegulationIsoquinolines

Stichwörter der Autor:innen

DNA synthesisREV-ERBcell proliferationcircadiankeratinocytesnuclear receptorsmall molecule

Substanzen

ThiophenesNuclear Receptor Subfamily 1, Group D, Member 1SR 8278NR1D1 protein, humanIsoquinolines

Autor:innen und Institutionen

  • Department of Pharmacology and Toxicology, Wright State University Boonshoft School of Medicine, Dayton, OH 45435, USA.
  • Department of Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, PA 15232, USA.
  • Dayton Veterans Affairs Medical Center, Dayton, OH 45428, USA.

ORCID-Profile: William Cvammen, Michael G Kemp

Förderung

  • NIGMS NIH HHS
  • National Institutes of Health
  • United States Department of Veterans Affairs
  • Ohio Cancer Research

Zitieren

APA

Atluri, U., Cvammen, W., & Kemp, M. G. (2026). The Small Molecule SR8278 Inhibits Cell Proliferation Independent of the REV-ERB Nuclear Receptor Proteins in Human Keratinocytes. Biomolecules. https://doi.org/10.3390/biom16030416

Vancouver

Atluri U, Cvammen W, Kemp MG. The Small Molecule SR8278 Inhibits Cell Proliferation Independent of the REV-ERB Nuclear Receptor Proteins in Human Keratinocytes. Biomolecules. 2026. doi:10.3390/biom16030416

BibTeX
@article{Atluri2026,
  author = {Atluri, Ushaswini and Cvammen, William and Kemp, Michael G},
  title = {The Small Molecule SR8278 Inhibits Cell Proliferation Independent of the REV-ERB Nuclear Receptor Proteins in Human Keratinocytes},
  journal = {Biomolecules},
  year = {2026},
  doi = {10.3390/biom16030416}
}
Kostenlos starten →